Azenta, Inc. (AZTA) Insider Trading Activity

NASDAQ$23.13-1.17 (-4.81%)
Market Cap
$1.12B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
178 of 883
Rank in Industry
13 of 49

AZTA Insider Trading Activity

AZTA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$605,574
6
67
Sells
$71,225
3
33

Related Transactions

Malus Alan Jdirector
1
$319,800
0
$0
$319,800
Cornog William Ldirector
3
$189,884
0
$0
$189,884
Lin Lawrence Y.EVP, CFO and Treasurer
1
$69,900
0
$0
$69,900
Marotta JohnPresident and CEO
1
$25,990
1
$9,294
$16,696
Pirogova OlgaSVP and CHRO
0
$0
1
$30,966
$-30,966
Zhou GingerSVP and GM, Multiomics
0
$0
1
$30,966
$-30,966

About Azenta, Inc.

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Insider Activity of Azenta, Inc.

Over the last 12 months, insiders at Azenta, Inc. have bought $605,574 and sold $71,225 worth of Azenta, Inc. stock.

On average, over the past 5 years, insiders at Azenta, Inc. have bought $888,568 and sold $4.71M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Malus Alan J (director) — $319,800. Cornog William L (director) — $189,884. Lin Lawrence Y. (EVP, CFO and Treasurer) — $69,900.

The last purchase of 2,500 shares for transaction amount of $69,900 was made by Lin Lawrence Y. (EVP, CFO and Treasurer) on 2025‑08‑11.

List of Insider Buy and Sell Transactions, Azenta, Inc.

2025-09-10SaleMarotta JohnPresident and CEO
316
0.0007%
$29.41
$9,294
+7.70%
2025-08-12SaleZhou GingerSVP and GM, Multiomics
1,085
0.0024%
$28.54
$30,966
+5.68%
2025-08-12SalePirogova OlgaSVP and CHRO
1,085
0.0024%
$28.54
$30,966
+5.68%
2025-08-11PurchaseLin Lawrence Y.EVP, CFO and Treasurer
2,500
0.0054%
$27.96
$69,900
+9.97%
2025-06-02PurchaseMarotta JohnPresident and CEO
1,000
0.0021%
$25.99
$25,990
+15.70%
2025-05-30PurchaseMalus Alan Jdirector
12,000
0.0261%
$26.65
$319,800
+15.25%
2025-05-20PurchaseCornog William Ldirector
2,748
0.0058%
$27.37
$75,213
+8.81%
2025-05-19PurchaseCornog William Ldirector
4,152
0.009%
$26.98
$112,021
+13.37%
2025-05-16PurchaseCornog William Ldirector
100
0.0002%
$26.50
$2,650
+11.87%
2025-02-03SaleHughes ViolettaVP, Chief Accounting Officer
317
0.0007%
$52.97
$16,791
-39.53%
2025-01-31PurchaseZhou GingerSVP and General Manager, Genom
417
0.0008%
$45.88
$19,132
-41.73%
2024-11-19SaleJoseph JasonSVP, General Counsel, Secy.
1,139
0.0023%
$40.07
$45,640
-22.94%
2024-11-19SaleZhou GingerSVP and General Manager, Genom
491
0.001%
$40.07
$19,674
-22.94%
2024-11-19SaleWang David DongSVP & GM, SMS
348
0.0007%
$40.07
$13,944
-22.94%
2024-11-19SaleCueto HermanEVP, Chief Financial Officer
712
0.0014%
$40.07
$28,530
-22.94%
2024-11-19SalePirogova OlgaSVP and CHRO
548
0.0011%
$40.07
$21,958
-22.94%
2024-11-19SaleHughes ViolettaVP, Chief Accounting Officer
163
0.0003%
$40.07
$6,531
-22.94%
2024-11-19PurchaseMarotta JohnPresident and CEO
1,250
0.0026%
$40.67
$50,838
-22.94%
2024-11-19PurchaseMadaus Martin Ddirector
4,940
0.0101%
$40.77
$201,404
-22.94%
2024-11-18PurchaseMarotta JohnPresident and CEO
12,716.98
0.0254%
$39.48
$502,066
-21.82%
Total: 299
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Marotta JohnPresident and CEO
105980
0.2301%
$2.58M31
<0.0001%
Lin Lawrence Y.EVP, CFO and Treasurer
46013
0.0999%
$1.12M10
Zhou GingerSVP and GM, Multiomics
26831
0.0583%
$651,993.3012
<0.0001%
Cornog William Ldirector
25795
0.056%
$626,818.5040
<0.0001%
Pirogova OlgaSVP and CHRO
18288
0.0397%
$444,398.4002
Malus Alan Jdirector
17035
0.037%
$413,950.5010
SCHWARTZ STEPHEN SCEO
379354
0.8236%
$9.22M046
Haris Clinton M.SVP, Brooks Life Sciences
160287
0.348%
$3.89M01
Tenney Maurice H.President-Brooks Life Sciences
136556
0.2965%
$3.32M012
Mirchandani KushSVP, Worldwide Sales
120792
0.2622%
$2.94M04
Joseph JasonSVP, General Counsel, Secy.
112564
0.2444%
$2.74M044
Robertson Lindon GEVP & Chief Financial Officer
100571
0.2183%
$2.44M220
+15%
Montone William T.SVP, Human Resources
91936
0.1996%
$2.23M044
MARTIN JOSEPH Rdirector
85175
0.1849%
$2.07M07
WOOLLACOTT ALFRED IIIdirector
84736
0.184%
$2.06M02
Gray David CChief Strategy & New Business
70610
0.1533%
$1.72M027
ALLEN A CLINTONdirector
69093
0.15%
$1.68M10
+46.23%
Mathews Timothy SPrincipal Accounting Officer
55846
0.1212%
$1.36M01
Jarzynka DavidPresident, Semi Solutions
46315
0.1006%
$1.13M018
McManus MatthewEVP & Chief Operating Officer
29467
0.064%
$716,048.1010
<0.0001%
Pietrantoni DavidPrincipal Accounting Officer
27375
0.0594%
$665,212.50035
Wang David DongSVP & GM, SMS
24114
0.0524%
$585,970.2001
Cueto HermanEVP, Chief Financial Officer
23892
0.0519%
$580,575.6002
Vacha RobinSVP, GM BLS-Products
22932
0.0498%
$557,247.6003
Liao GuojuanPresident, GENEWIZ
12827
0.0278%
$311,696.1002
Hughes ViolettaVP, Chief Accounting Officer
9603
0.0208%
$233,352.9002
MCGILLICUDDY JOHN Kdirector
9500
0.0206%
$230,850.0002
Madaus Martin Ddirector
7405
0.0161%
$179,941.5010
<0.0001%
Crowley KimberlySVP, Chief HR Officer
5133
0.0111%
$124,731.9001
Rosenblatt Michaeldirector
5051
0.011%
$122,739.3002
Davis Robyn Cdirector
3569
0.0077%
$86,726.7001
HIRSCH DIDIERdirector
3465
0.0075%
$84,199.5010
<0.0001%
De Jesus LindaChief Commercial Officer, LS
2721
0.0059%
$66,120.3001
*Gray background shows insiders who have made transactions during last year

AZTA Institutional Investors: Active Positions

Increased Positions148+45.68%7M+13.73%
Decreased Positions140-43.21%4M-8.95%
New Positions52New3MNew
Sold Out Positions34Sold Out2MSold Out
Total Postitions332+2.47%52M+4.78%

AZTA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$230,521.0015.01%6.9M-602,040-8.02%2025-09-30
Politan Capital Management Lp$154,155.0010.04%4.62M00%2025-09-30
Vanguard Group Inc$148,230.009.65%4.44M-123,522-2.71%2025-09-30
Dimensional Fund Advisors Lp$84,136.005.48%2.52M-199,026-7.32%2025-09-30
State Street Corp$57,053.003.72%1.71M-83,921-4.68%2025-09-30
Millennium Management Llc$56,715.003.69%1.7M+499,216+41.62%2025-09-30
Conestoga Capital Advisors, Llc$49,016.003.19%1.47M-450,370-23.48%2025-09-30
Allspring Global Investments Holdings, Llc$43,011.002.8%1.29M-57,100-4.25%2025-09-30
Gw&K Investment Management, Llc$37,746.002.46%1.13M-121,069-9.67%2025-09-30
Geode Capital Management, Llc$34,105.002.22%1.02M-43,037-4.04%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.